Quantitative analysis of regional distribution of tau pathology with 11C-PBB3-PET in a clinical setting.

Elham Yousefzadeh-NowshahrGordon WinterPeter BohnKatharina KneerChristine A F von ArnimMarkus OttoChristoph SolbachSarah Anderl-StraubDörte PolivkaPatrick FisslerJoachim StrobelPeter KlettingMatthias W RiepeMakoto HiguchiGerhard GlattingAlbert LudolphAmbros J Beernull null

Published in: PloS one (2022)

Our results suggest that 11C-PBB3-PET can effectively analyze regional tau load and has the potential to differentiate patients in the AD continuum group from the BN and SNAP group.

Keyphrases

end stage renal disease
computed tomography
positron emission tomography
ejection fraction
pet ct
chronic kidney disease
newly diagnosed
cerebrospinal fluid
prognostic factors
peritoneal dialysis
pet imaging
risk assessment